Fluxergy seeks emergency authorization for 1-hour coronavirus test

2020 01 27 21 38 4451 Lab 2019 Coronavirus Test 400

Fluxergy is seeking an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to pave the way for medical professionals to use its one-hour, research-use-only, point-of-care test for the novel coronavirus.

According to the company, only a very small sample -- typically a nasal swab -- is needed for testing. The swab is mixed with a reagent solution and loaded onto a single-use Fluxergy lab-on-a-chip card, which is inserted into the company's Fluxergy analyzer, the company explained.

The test identified SARS-CoV-2 in less than an hour in bench lab validation tests recently performed by researchers at the University of California, San Diego (UCSD), Fluxergy said.

Page 1 of 68
Next Page